These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37494473)

  • 1. Signatures of AAV-2 immunity are enriched in children with severe acute hepatitis of unknown etiology.
    Mitchell MM; Leng Y; Boppana S; Britt WJ; Gutierrez Sanchez LH; Elledge SJ
    Sci Transl Med; 2023 Jul; 15(706):eadh9917. PubMed ID: 37494473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Hepatitis of Unknown Etiology Presenting as Pediatric Acute Liver Failure: Analysis of Likely Etiology, Clinical Course and Outcome.
    Lal BB; Sood V; Gupta E; Agarwal R; Khanna R; Alam S
    J Clin Exp Hepatol; 2023 May; 13(5):912-6. PubMed ID: 37360874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis of unknown origin in children: A combination of factors.
    Gong K; Xu X; Yao J; Ye S; Yu X; Tu H; Lan Y; Fan YC; Shi Y
    Front Pharmacol; 2022; 13():1056385. PubMed ID: 36438816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adeno-associated virus 2 and severe acute hepatitis of unknown etiology in Japanese children.
    Iwata KI; Torii Y; Sakai A; Fukuda Y; Haruta K; Yamaguchi M; Suzuki T; Etani Y; Takahashi Y; Umetsu S; Inui A; Sumazaki R; Kawada JI
    J Infect Chemother; 2024 Jul; ():. PubMed ID: 38969101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom.
    Gates S; Andreani J; Dewar R; Smith DB; Templeton K; Child HT; Breuer J; Golubchik T; Bassano I; Wade MJ; Jeffries AR; Simmonds P; Harvala H
    J Med Virol; 2023 Jul; 95(7):e28921. PubMed ID: 37403889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA.
    Ikeda H; Takasu M; Inoue K; Okamoto H; Miyakawa Y; Mayumi M
    J Hepatol; 1999 Feb; 30(2):205-12. PubMed ID: 10068097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, treatment, and prevention of severe acute hepatitis of unknown etiology in children.
    Chen YH; Lou JG; Yang ZH; Chen QJ; Hua CZ; Ye S; Zhang CM; Chen J; Huang ZW; Yu JD; Gao ZG; Shu Q
    World J Pediatr; 2022 Aug; 18(8):538-544. PubMed ID: 35771382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute severe non-A-E-hepatitis of unknown origin in children - A 30-year retrospective observational study from north-west Germany.
    Leiskau C; Tsaka S; Meyer-Ruhnke L; Mutschler FE; Pfister ED; Lainka E; Baumann U
    J Hepatol; 2023 May; 78(5):971-978. PubMed ID: 36572350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between HLA-DPB1 and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Children.
    Gibson KM; Drögemöller BI; Foell D; Benseler SM; Graham J; Hancock REW; Luqmani RA; Cabral DA; Brown KL; Ross CJ;
    Arthritis Rheumatol; 2023 Jun; 75(6):1048-1057. PubMed ID: 36530128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consideration on the possible etiological mechanisms and countermeasures about severe acute hepatitis of unknown origin in children].
    Wang LJ; Yu GX; Wu Y; Yang XY; Gao Y; Wang L; Chen XM; Lu FM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1499-1504. PubMed ID: 36274621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome.
    Aronson SJ; Veron P; Collaud F; Hubert A; Delahais V; Honnet G; de Knegt RJ; Junge N; Baumann U; Di Giorgio A; D'Antiga L; Ginocchio VM; Brunetti-Pierri N; Labrune P; Beuers U; Bosma PJ; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1297-1305. PubMed ID: 31502485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus in the liver: natural history and consequences in tumour development.
    La Bella T; Imbeaud S; Peneau C; Mami I; Datta S; Bayard Q; Caruso S; Hirsch TZ; Calderaro J; Morcrette G; Guettier C; Paradis V; Amaddeo G; Laurent A; Possenti L; Chiche L; Bioulac-Sage P; Blanc JF; Letouze E; Nault JC; Zucman-Rossi J
    Gut; 2020 Apr; 69(4):737-747. PubMed ID: 31375600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?
    Pérez-Gracia MT; Tarín-Pelló A; Suay-García B
    J Clin Transl Hepatol; 2022 Aug; 10(4):711-717. PubMed ID: 36062273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pay close attention to the current characteristics and development trend of severe acute hepatitis with unknown etiology in children worldwide].
    Ma K; Yang ZY; Chen T; Luo XP; Ning Q
    Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(24):1790-1793. PubMed ID: 35725361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes.
    Berraondo P; Ochoa L; Crettaz J; Rotellar F; Vales A; Martínez-Ansó E; Zaratiegui M; Ruiz J; González-Aseguinolaza G; Prieto J
    Mol Ther; 2005 Jul; 12(1):68-76. PubMed ID: 15963922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo.
    Hösel M; Lucifora J; Michler T; Holz G; Gruffaz M; Stahnke S; Zoulim F; Durantel D; Heikenwalder M; Nierhoff D; Millet R; Salvetti A; Protzer U; Büning H
    Hepatology; 2014 Jun; 59(6):2110-20. PubMed ID: 24425003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
    Grimm D; Lee JS; Wang L; Desai T; Akache B; Storm TA; Kay MA
    J Virol; 2008 Jun; 82(12):5887-911. PubMed ID: 18400866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.
    Berns KI; Srivastava A
    Gastroenterol Clin North Am; 2019 Jun; 48(2):319-330. PubMed ID: 31046978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.